Abstract
Although both unplanned pregnancy rates and abortion rates are high and effective methods of contraception and emergency contraception are available, the use of contraception is low. Emergency contraception is a backup method of contraception which provides women last chance to prevent pregnancy and it should not be used as regular contraception. In most countries current options for emergency contraception (EC) include: hormonal contraception, i.e. levonorgestrel (LNG) EC pills available behind the counter and ulipristate acetate EC pills available as prescription only, and copper intra uterine device (IUCD). Accessibility and ease of use favors hormonal EC over an IUCD for EC. EC pills are most effective if used in the first 24 h after intercourse. LNG is approved for use up to 72 h of unprotected intercourse, while UPA is approved up to 5 days of unprotected intercourse. IUCD is the most effective form of EC and it can be used even after 5 days of unprotected sexual intercourse. LNG has been used for several decades and it is safe for use by all women including adolescents. Thus is available in many countries as behind the counter emergency contraceptive. UPA has been used only for several years and its safety profile is not as well characterized. It is available only with a prescription. The most frequently reported adverse reactions to Vigibase (WHO data base) when LNG was used as EC were: irregular menstruations, nausea, and pelvic pain, vomiting, and delayed menstruations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ashok PW, Wagaarachchi PT, Flett GM, Templeton A (2001) Mifepristone as a late post-coital contraceptive. Hum Reprod 16:72–75
Brache V, Cochon L, Deniaud M, Croxatto HB (2013) Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception 88:611–618
Brito KS, Bahamondes L, Nascimento JA, de Santis L, Munuce MJ (2005) The in vitro effect of emergency contraception doses of levonorgestrel on the acrosome reaction of human spermatozoa. Contraception 72(3):225–228
Center for Drug Evaluation and Research (CDER) Application number 21–998
CEU Guidance on Quick Starting Contraception (2010) http://www.fsrh.org/pdfs/CEUGuidanceQuickStartingContraception.pdf
Cheng L, Che Y, Gulmezoglu AM (2012) Interventions for emergency contraception. Cochrane Database Syst Rev 8, CD001324
Cooper RJ, Bissell P, Wingfield J (2008) Ethical, religious and factual beliefs about the supply of emergency hormonal contraception by UK community pharmacists. J Fam Plann Reprod Health Care 34(1):47–50
Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, Rosenberg M, Higgins J (2006) Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 108:1089–1097
Croxatto HB, Fuentalba B, Brache V, Salvatierra AM, Alvarez F, Massai R, Cochon L, Faundes A (2002) Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function. Contraception 65:121–128
Croxatto HB, Brache V, Pavez M, Cochon L, Forcelledo ML, Alvarez F et al (2004) Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception 70:442–450
Daniels K, Jones J, Abma J (2013) Use of emergency contraception among women aged 15–44: United States, 2006–2010. NCHS Data Brief 112
Davis V, Dun S (2000) Emergency postcoital contraception. SOGC clinical practice guidelines No. 92
Durand M, del Carmen Cravioto M, Raymond EG, De la Luz Cruz-Hinojosa M et al (2001) On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 64:227–234
Ella 2014 (ulipristal acetate) tablet prescribing information. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022474s004lbl.pdf
Emergency contraception (2010) Catholics in favor, bishops opposed. International consortium for emergency contraception. Available at http://www.catholicsforchoice.org/documents/EmergencyContraceptionCatholicsinFavor.pdf
Emergency Contraception. Teenage sexual and reproductive behavior in the United States. The changing face of teen sexual activity and unplanned pregnancy. Available at http://kff.org/womens-health-policy/emergency-contraception/
Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit Guidance (2010) CEU guidance on quick starting contraception. Quick starting contraception. Faculty of Sexual and Reproductive Healthcare, London. ISSN 1755-103x. http://www.fsrh.org/pdfs/CEUGuidanceQuickStartingContraception.pdf
Faculty of Sexual & Reproductive Healthcare Clinical Guidance (FFPHRC) (2012) Emergency Contraception Clinical Effectiveness Unit August 2011 (updated Jan 2012), pp 1–27. http://www.fsrh.org/pages/Clinical_Guidance_2.asp
Faculty of Sexual and Reproductive Healthcare (FSRHCU) (2013) Use of ulipristal acetate (ellaOne®) in breastfeeding women. Update from the Clinical Effectiveness Unit. March 2013. Faculty of Sexual and Reproductive Healthcare, London
Farley TMM, Rosenberg MJ, Rowe PJ, Chen J-H, Meirik O (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339:785–788
FDA (2009) Plan B One Step (levonorgestrel) tablet 1.5 mg, for oral use, revised 2009 http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf
Food and Drug Administration (1997) Prescription drug products: certain combined oral contraceptives for use as postcoital emergency contraception. Fed Regist 62:8610–8612
Gainer E, Kenfack B, Mboudou E, Doh AS, Bouyer J (2006) Menstrual bleeding patterns following levonorgestrel emergency contraception. Contraception 74(2):118–124
Gemzell-Danielsson K, Marions L (2004) Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. Hum Reprod 10(4):341–348
Gemzell-Danielsson K, Berger C, Lalitkumar PG (2014) Mechanisms of action of oral emergency contraception. Gynecol Endocrinol 12:1–3
Glasier A (1997) Emergency postcoital contraception. N Engl J Med 337:1058–1064
Glasier A, Thong KJ, Dewar M et al (1992) Mifepristone (RU486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 327:1041–1044
Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E (2010) Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-analysis. Lancet 375:555–562
Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, Gainer E, Ulmann A (2011) Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 84:363–367
Habel MA, Leichliter JS (2012) Emergency contraception and risk for sexually transmitted infections among U.S. women. J Womens Health 21(9):910–916
Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N et al (2003) The interaction between St John’s wort and an oral contraceptive. Clin Pharmacol Ther 74(6):525–535
Halpern V, Raymond EG, Lopez LM (2010) Repeated use of pre- and postcoital hormonal contraception for prevention of pregnancy. Cochrane Database Syst Rev 2010(1), CD007595. doi:10.1002/14651858.CD007595.pub2
Harper C, Weiss D, Speidel J, Raine-Bennett T (2008) Over-the-counter access to emergency contraception for teens. Contraception 77:230–233
Harper CC, Speidel JJ, Drey EA, Trussell J, Blum M, Darney PD (2012) Copper intrauterine device for emergency contraception: clinical practice among contraceptive providers. Obstet Gynecol 119:220–226
http://www.umc-products.com/DynPage.aspx?id=73471&mn1=1108. Aug 2014
Hubacher D, Lara‐Ricalde R, Taylor DJ, Guerra‐Infante F, Guzmán‐Rodríguez R (2001) Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 345:561–567
Ilic K (2013) Pharmacovigilance and effectiveness of emergency contraception. 13th ISoP annual meeting, Pisa, October 1–4, 2013. Drug Saf 36(9):935
International Consortium for Emergency Contraception. http://www.cecinfo.org/country-by-country-information/status-availability-database/countries. Accessed July 2014
Johansson E, Brache V, Alvarez F, Faundes A, Cochon L, Ranta S, Lovern M, Kumar N (2002) Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum Reprod 17(6):1472–1476
Jones RK, Darroch JE, Henshaw SK (2002) Contraceptive use among US women having abortions in 2000–2001. Perspect Sex Reprod Health 34:294–303
Judicial Review of Emergency Contraception (2002) National Guideline Clearinghouse. Guideline summary NGC – 8895. Available at http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publichealth/Healthimprovement/Sexualhealth/Sexualhealthgeneralinformation/DH_4063853
Katzman DK, Taddeo D, Canadian Paediatric Society, Adolescent Health Committee (2010) Emergency contraception. Paediatr Child Health 15(6):363–372
Kesseru E, Garmendia F, Westphal N, Parada J (1974) The hormonal and peripheral effects of d-norgestrel in postcoital contraception. Contraception 10(4):411–424
Kesseru E, Camacho-Ortega P, Laudahn G, Schopflin G (1975) In vitro action of progestogens on sperm migration in human cervical mucus. Fertil Steril 26(1):57–61
Kost K, Henshaw S (2014) U.S. Teenage pregnancies, births and abortions, 2010: National and state trends by age, race and ethnicity. Guttmacher Institute. May 2014. Available at http://www.guttmacher.org/datacenter/trend.jsp
Kozinszky Z, Bakken RT, Lieng M (2011) Ectopic pregnancy after levonorgestrel emergency contraception. Contraception 83(3):281–283
Larsson G, Milsom I, Jonasson K, Lindstedt G, Rybo G (1993) The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception 48(5):471–480
Leung VWY, Levine M, Soon J (2010) Mechanisms of action of hormonal emergency contraceptives. Pharmacotherapy 30(2):158–168
Levonelle® Summary of product characteristics. http://www.medicines.org.uk/emc/history/16887. Accessed 20 Oct 2014
Milsom I, Rybo G, Lindstedt G (1990) The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception 41(3):271–281
Moreau C, Trussell J (2012) Results from pooled Phase III studies of ulipristal acetate for emergency contraception. Contraception 86:673–680
Mosher WD, Jones J (2010) Use of contraception in the United States: 1982–2008. National Center for Health Statistics. Vital Health Stat 23. Available at: http://www.cdc.gov/NCHS/
Müller AL, Llados CM, Croxatto HB (2003) Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat. Contraception 67:415–419
Ngai SW, Fan S, Li S, Cheng L, Ding J, Jing X, Ng EHY, Ho PC (2004) A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception. Hum Reprod 20:307–311
Noé G, Croxatto HB, Salvatierra AM, Reyes V, Villarroel C, Muñoz C, Morales G, Retamales A (2011) Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception 84(5):486–492
Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser IS (2007) Effectiveness of levonorgestrel emergency contraception given before or after ovulation-a pilot study. Contraception 75(2):112–118
Piaggio G, Kapp N, von Hertzen H (2011) Effect on pregnancy rates of the delay in administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception 84:35–39
Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA (2007) Advance provision of emergency contraception for pregnancy prevention. Cochrane Database Syst Rev 2, CD005497
Prescribing Information Plan B One-Step (levonorgestrel) July 2009. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf
Raymond EG, Felicia S, Weaver M, Monteith C, Van Der Pol B (2006) Impact of increased access to emergency contraceptive pills: a randomized controlled trial. Obstet Gynecol 108:1098–1106
Raymond EG, Trussell J, Polis C (2007) Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol 109:181–188
Raymond EG, Shannon C, Weaver MA, Winikoff B (2013) First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception 87:26–37
Richardson AR, Maltz FN (2012) Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception. Clin Ther 34:24–36
Rodriguez MI, Godfrey EM, Warden M, Curtis KM (2013) Prevention and management of nausea and vomiting with emergency contraception: a systematic review. Contraception 87:583–589
Rowlands S, Kubba AA, Guillebaud J, Bounds W (1986) A possible mechanism of action of danazol and an ethinylestradiol/norgestrel combination used as postcoital contraceptive agents. Contraception 33:539–545
Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S (1999) Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 59(1):1–6
Swahn ML, Westlund P, Johannisson E, Bygdeman M (1996) Effect of post‐coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstet Gynecol Scand 75:738–744
Tadiar FM, Robinson ET (1996) Legal, ethical and regulatory aspects of introducing emergency contraception in the Philippines. Int Fam Plan Perspect 22(2):76–80. Available at http://www.guttmacher.org/pubs/journals/2207696.pdf
Task Force on Postovulatory Methods of Fertility Regulation (1998) Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 352:428–433
Trussell J, Raymond EG (2014) Emergency contraception: a last chance to prevent unintended pregnancy. Available at: http://ec.princeton.edu/questions/ec-review.pdf
Van Riper KK, Hellerstedt WL (2005) Emergency contraceptive pills: dispensing practices, knowledge and attitudes of South Dakota pharmacists. Perspect Sex Reprod Health 37(1):19–24
von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, Ng E, Gemzell-Danielsson K, Oyunbileg A, Wu S, Cheng W, Lüdicke F, Pretnar-Darovec A, Kirkman R, Mittal S, Khomassu-Ridze A, Apter D, Peregoudov A, WHO Research Group on Post-ovulatory Methods of Fertility Regulation (2002) Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 360(9348):1803–1810
Webb AMC, Russell J, Elstein M (1992) Comparison of Yuzpe regimen, danazol, and mifepristone (RU 486) in oral postcoital contraception. BMJ 305:927–931
Westhoff C (2003) Emergency contraception. N Engl J Med 349:1830–1835
WHO (2010a) Medical eligibility criteria for contraceptive use: a WHO family planing cornerstone, 4th edn. WHO, Geneva
WHO (2010b) Fact sheet on the safety of levonorgestrel-alone emergency contraceptive pills (LNG ECPs)
WHO, UNFPA, UNAIDS, FHI (2011) The TCu380A Intrauterine Contraceptive Device (IUD): Specification, Prequalification and Guidelines for Procurement, 2010
Wood AJJ, Drazen JM, Greene MF (2012) The politics of emergency contraception. N Engl J Med 366(2):101–102
World Health Organization Task Force on Postovulatory Methods of Fertility Regulation (1998) Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 352:428–433
World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation, Special Programme of Research, Development and Research Training, World Health Organisation (2000) Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG 107(4):524–530
Wu S, Godfrey EM, Wojdyla D, Dong J, Cong J, Wang C, von Hertzen H (2010) T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 117(10):1205–1210
Yeung WS, Chiu PC, Wang CH, Yao YQ, Ho PC (2002) The effects of levonorgestrel on various sperm functions. Contraception 66(6):453–457
Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI (1974) Post coital contraception – a pilot study. J Reprod Med 13(2):53–58
Zhang L, Chen J, Wang Y, Ren F, Yu W, Cheng L (2009) Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 24:1605–1611
Acknowledgment
I am grateful to Ivana Macenovski–Colic Pharm D, former student of mine, for her help with preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ilic, K. (2015). Emergency Contraception. In: Harrison-Woolrych, M. (eds) Medicines For Women. Adis, Cham. https://doi.org/10.1007/978-3-319-12406-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-12406-3_7
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-12405-6
Online ISBN: 978-3-319-12406-3
eBook Packages: MedicineMedicine (R0)